Switzerland· 65212001
18F-Fluoroglukose ZRP 0.5 - 5 GBq/ml, Injektionslösung zur i.v. Applikation
A fludeoxyglucose (18f) product containing fludeoxyglucosum(18f), registered in Switzerland by Universitätsspital Zürich and dispensed under Swissmedic category A. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Fludeoxyglucose (18f) is registered in 11 of 19 countries.
Countries holding a registration under ATC V09IX04 (fludeoxyglucose (18f)), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 6 of them publish a price we can compare per daily dose
Fludeoxyglucose (18f) · ATC V09IX04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- fludeoxyglucosum(18F)
- Manufacturer
- Universitätsspital Zürich
- Country
- Switzerland (CH)
- ATC code
- V09IX04
- ATC class
- Fludeoxyglucose (18F)
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
46 interactions on record for fludeoxyglucose (18f).
Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fludeoxyglucose (18f) · interactions on record
46 records
- 46 moderate
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Liquid paraffinA06AA01moderate
- BisacodylA06AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V09IX04
Fludeoxyglucose (18f), as other registers publish it.
- Czechia(18F)FDG-FRAlliance Medical RP Berlin GmbH, Berlin
- Germany[18f]-Fdg-Fzk Zag ZyklotronZag Zyklotron Ag
- Germany[18f]fdgEuro-Pet Gmbh
- Netherlands[18F]FDG Alliance Medical 300-3100 MBq/ml oplossing voor injectieAlliance Medical RP Berlin GmbH
- Germany[18f]fdg-LeUniversitaetsklinikum Leipzig Aoer
- Germany[18f]fludeoxyglucoseAlliance Medical Rp Berlin Gmbh
- Canada[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTIONSYLVIA FEDORUK CANADIAN CENTRE FOR NUCLEAR INNOVATION
- Netherlands18F-FDG Hoboken 250 MBq/ml, oplossing voor injectieTheranostics Erasmus MC B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf2d43e3-8c2e-4acd-a7ca-1c32ec78152b GET /v1/drugs/bf2d43e3-8c2e-4acd-a7ca-1c32ec78152b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Radiopharmazeutika"
}See everything about fludeoxyglucose (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.